Journey Medical Corp. (DERM)
7.86
+0.16
(+2.08%)
USD |
NASDAQ |
Dec 16, 15:01
Journey Medical Research and Development Expense (Annual): 9.857M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Fortress Biotech, Inc. | 56.88M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |
| Theriva Biologics, Inc. | 12.03M |
| Oragenics, Inc. | 4.114M |